Richard Mei is a Senior Managing Director at Leerink Partners focused on Equity-Linked Capital Markets.
Prior to joining the Firm in 2018, Richard was a member of the corporate finance team at Regeneron Pharmaceuticals. He has over 16 years of experience advising companies on convertible financing, equity derivatives, and liability management. Prior to Regeneron, he spent over a decade at Bank of America Merrill Lynch in various investment banking and capital markets roles.
He earned an M.B.A. from New York University and a B.S. from the University of California at Berkeley.